|
Doxybactin vet
|
400 mg
|
V/DCP/17/0033
|
Dechra Regulatory B.V., Nīderlande
|
QJ01AA02
|
dogs
|
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Doxycyclin hyclate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Aug-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 29112022LI (29-Nov-2022)
|
| Labelling text: |
[DOCX] 29112022M (29-Nov-2022)
|
| Summary of product characteristics: |
[DOCX] 29112022ZA (29-Nov-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0033-01 |
400 mg |
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0033-02 |
400 mg |
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0033-03 |
400 mg |
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0033-04 |
400 mg |
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0033-05 |
400 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Doxybactin vet
|
200 mg
|
V/DCP/17/0032
|
Dechra Regulatory B.V., Nīderlande
|
QJ01AA02
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Doxycyclin hyclate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Aug-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 29112022LI (29-Nov-2022)
|
| Labelling text: |
[DOCX] 29112022M (29-Nov-2022)
|
| Summary of product characteristics: |
[DOCX] 29112022ZA (29-Nov-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0032-01 |
200 mg |
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0032-02 |
200 mg |
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0032-03 |
200 mg |
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0032-04 |
200 mg |
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0032-05 |
200 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Doxybactin vet
|
50 mg
|
V/DCP/17/0031
|
Dechra Regulatory B.V., Nīderlande
|
QJ01AA02
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Doxycyclin hyclate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande
|
| Date of authorisation/renewal: |
26-Aug-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 29112022LI (29-Nov-2022)
|
| Labelling text: |
[DOCX] 29112022M (29-Nov-2022)
|
| Summary of product characteristics: |
[DOCX] 29112022ZA (29-Nov-2022)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/17/0031-01 |
50 mg |
1 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0031-02 |
50 mg |
2 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0031-03 |
50 mg |
3 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0031-04 |
50 mg |
10 |
Blisteris, 10 tablete |
-
|
| V/DCP/17/0031-05 |
50 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|